Claudia Cava
Claudia Cava
Verified email at
Cited by
Cited by
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
A Colaprico, TC Silva, C Olsen, L Garofano, C Cava, D Garolini, ...
Nucleic acids research 44 (8), e71-e71, 2016
MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer
G Bertoli, C Cava, I Castiglioni
Theranostics 5 (10), 1122, 2015
MicroRNAs as biomarkers for diagnosis, prognosis and theranostics in prostate cancer
G Bertoli, C Cava, I Castiglioni
International journal of molecular sciences 17 (3), 421, 2016
In silico discovery of candidate drugs against Covid-19
C Cava, G Bertoli, I Castiglioni
Viruses 12 (4), 404, 2020
Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition
C Cava, G Bertoli, M Ripamonti, G Mauri, I Zoppis, PA Della Rosa, ...
PloS one 9 (5), e97681, 2014
Comparison of data-merging methods with SVM attribute selection and classification in breast cancer gene expression
VB Stefania Tommasi, Paolo Pannarale, Mirko Abbrescia, Claudia Cava
Lecture Notes in Computer Science (including subseries Lecture Notes iná…, 2011
Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
C Cava, G Bertoli, I Castiglioni
BMC systems biology 9 (1), 1-36, 2015
Integrative analysis with Monte Carlo cross-validation reveals miRNAs regulating pathways cross-talk in aggressive breast cancer
A Colaprico, C Cava, G Bertoli, G Bontempi, I Castiglioni
BioMed research international 2015, 2015
SpidermiR: an R/bioconductor package for integrative analysis with miRNA data
C Cava, A Colaprico, G Bertoli, A Graudenzi, TC Silva, C Olsen, ...
International journal of molecular sciences 18 (2), 274, 2017
Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer
L Cantini, G Bertoli, C Cava, T Dubois, A Zinovyev, M Caselle, ...
Nucleic acids research 47 (5), 2205-2215, 2019
Integration of multiple networks and pathways identifies cancer driver genes in pan-cancer analysis
C Cava, G Bertoli, A Colaprico, C Olsen, G Bontempi, I Castiglioni
BMC genomics 19 (1), 1-16, 2018
The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer
G Bertoli, C Cava, I Castiglioni
Scandinavian Journal of Clinical and Laboratory Investigation 76 (sup245á…, 2016
MicroRNA-567 dysregulation contributes to carcinogenesis of breast cancer, targeting tumor cell proliferation, and migration
G Bertoli, C Cava, C Diceglie, C Martelli, G Rizzo, F Piccotti, L Ottobrini, ...
Breast cancer research and treatment 161 (3), 605-616, 2017
Potential role of miRNAs as theranostic biomarkers of epilepsy
C Cava, I Manna, A Gambardella, G Bertoli, I Castiglioni
Molecular Therapy-Nucleic Acids 13, 275-290, 2018
How interacting pathways are regulated by miRNAs in breast cancer subtypes
C Cava, A Colaprico, G Bertoli, G Bontempi, G Mauri, I Castiglioni
BMC bioinformatics 17 (12), 111-133, 2016
Radiation-induced gene expression changes in high and low grade breast cancer cell types
V BravatÓ, C Cava, L Minafra, FP Cammarata, G Russo, MC Gilardi, ...
International journal of molecular sciences 19 (4), 1084, 2018
Combined analysis of chromosomal instabilities and gene expression for colon cancer progression inference
C Cava, I Zoppis, M Gariboldi, I Castiglioni, G Mauri, M Antoniotti
Journal of clinical bioinformatics 4 (1), 1-15, 2014
Combination of gene expression and genome copy number alteration has a prognostic value for breast cancer
C Cava, I Zoppis, G Mauri, M Ripamonti, F Gallivanone, C Salvatore, ...
2013 35th Annual International Conference of the IEEE Engineering iná…, 2013
Copy–number alterations for tumor progression inference
C Cava, I Zoppis, M Gariboldi, I Castiglioni, G Mauri, M Antoniotti
Conference on Artificial Intelligence in Medicine in Europe, 104-109, 2013
In silico identification of drug target pathways in breast cancer subtypes using pathway cross-talk inhibition
C Cava, G Bertoli, I Castiglioni
Journal of translational medicine 16 (1), 1-17, 2018
The system can't perform the operation now. Try again later.
Articles 1–20